1. Guozheng Huang, Simon Schramm, J?rg Heilmann, David Biedermann, Vladimír K?en, and Michael Decker. Unconventional application of the Mitsunobu reaction: selective flavonolignan dehydration yielding hydnocarpins. Beilstein Journal of Organic Chemistry. 2016, 12, 662–669.
2. Guozheng Huang, Martin Nimczick, Michael Decker. Rational modification of the biological profile of GPCR ligands through combination with other biologically active moieties. Archiv der Pharmazie - Chemistry in Life Sciences. 2015, 348, 531–540
3. Guozheng Huang, Beata Kling, Darras H. Fouad, J?rg Heilmann, Michael Decker. Identification of a neuroprotective and selective butyrylcholinesterase inhibitor derived from the natural alkaloid evodiamine. European Journal of Medicinal Chemistry, 2014, 81, 15-21.
4. Guozheng Huang, Daniela Pemp, Patricia Stadtmüller, Martin Nimczick, J?rg Heilmann, Michael Decker. Design, synthesis and in vitro evaluation of novel uni- and bivalent ligands for the cannabinoid receptor 1 with variation of spacer length and composition. Bioorganic & Medicinal Chemistry Letters, 2014, 22, 4209-4214.
5. Guozheng Huang, Dominika Roos, Patricia Stadtmüller, Michael Decker. A simple fusion reaction and its application for expeditious syntheses of rutaecarpine and its analogs. Tetrahedron Letters, 2014, 55, 3607-3609.
6. Fouad H. Darras, Steffen Pockes, Guozheng Huang, Sarah Wehle, Andrea Strasser, Hans-Joachim Wittmann, Martin Nimczick, Christoph Sotriffer, Michael Decker. Synthesis, biological evaluation, and computational studies of tri- and tetracyclic nitrogen-bridgehead compounds as potent dual-acting AChE inhibitors and hH3 receptor antagonists. ACS Chemical Neuroscience. 2014, 5, 225-242.
7. Fouad H. Darras, Sarah Wehle, Guozheng Huang, Christoph Sotriffer, Michael Decker. Amine substitution of quinazolinones leads to selective nanomolar AChE inhibitors with an “inverted” binding mode. Bioorganic & Medicinal Chemistry, 2014, 22, 4867-4881.